[HTML][HTML] Cefiderocol: a novel agent for the management of multidrug-resistant Gram-negative organisms
JY Wu, P Srinivas, JM Pogue - Infectious diseases and therapy, 2020 - Springer
Abstract Cefiderocol, formerly S-649266, is a first in its class, an injectable siderophore
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
JY Wu, P Srinivas, JM Pogue - Infectious Diseases and Therapy, 2020 - go.gale.com
Cefiderocol, formerly S-649266, is a first in its class, an injectable siderophore
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms.
JY Wu, P Srinivas, JM Pogue - Infectious Diseases and Therapy, 2020 - europepmc.org
Abstract Cefiderocol, formerly S-649266, is a first in its class, an injectable siderophore
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
JY Wu, P Srinivas, JM Pogue - Infectious Diseases and …, 2020 - search.proquest.com
Abstract Cefiderocol, formerly S-649266, is a first in its class, an injectable siderophore
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms.
JY Wu, P Srinivas, JM Pogue - Infectious Diseases & …, 2020 - search.ebscohost.com
Abstract Cefiderocol, formerly S-649266, is a first in its class, an injectable siderophore
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
JY Wu, P Srinivas, JM Pogue - Infectious diseases and …, 2020 - pubmed.ncbi.nlm.nih.gov
Cefiderocol, formerly S-649266, is a first in its class, an injectable siderophore
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
Cefiderocol: a novel agent for the management of multidrug-resistant Gram-negative organisms.
JY Wu, P Srinivas, JM Pogue - 2020 - cabidigitallibrary.org
Abstract Cefiderocol, formerly S-649266, is a first in its class, an injectable siderophore
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
[HTML][HTML] Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
JY Wu, P Srinivas, JM Pogue - Infectious Diseases and Therapy, 2020 - ncbi.nlm.nih.gov
Abstract Cefiderocol, formerly S-649266, is a first in its class, an injectable siderophore
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …
cephalosporin that combines a catechol-type siderophore and cephalosporin core with side …